Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

Should you invest in Bicara Therapeutics Inc? Click for more on BCAX's promising cancer treatment, but proceed with caution ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Ladies and gentlemen, thank you for joining us today. Welcome to ...

Revolution Medicines, Inc. (NASDAQ: RVMD) Q3 2024 Earnings Call Transcript November 6, 2024 Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-0.94 EPS, expectations were ...

How have -- I know you just set up the payer team, but how have initial payer discussions been going for pembrolizumab and SMA ... and we're going to continue to do our work and we'll continue to ...

"We think the work we're doing now does have general applicability to other solid tumors ... patients with glioblastoma ...

The US does not have a regulator to control drug ... An example of the process is Merck’s blockbuster immuno-oncology drug Keytruda (pembrolizumab) which was originally discovered by academics.

With a clearly defined regulatory path forward for Nana-val, we believe this will allow us to be efficient while we work toward the possible submission ... valganciclovir, and pembrolizumab for ...

As a result, Transgene is conducting preliminary work on a potential new Phase I trial in a further ... Notably, BT-001 in combination with pembrolizumab showed first signs of efficacy in 2 out of 6 ...

Reprioritized resources to reduce costs and enhance focus on Nana-val's development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report data ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the ...

Addition of the immunotherapy drug pembrolizumab to standard of care for patients with advanced soft tissue sarcoma of the limb significantly improved disease-free survival, according to the results ...